Specifically, human astrocytes have been shown both to upregulate BAFF in vivo in MS lesions and to secrete this key plasma cell survival factor after ex vivo treatment with IFN-g and TNF-a (152). The gene discussed is TNFSF13B; the disease is myeloid sarcoma.